HEPATOBILIARY MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE
作者： Vivek Raj , David R. Lichtenstein
DOI: 10.1016/S0889-8553(05)70067-4
关键词: Gastroenterology 、 Primary sclerosing cholangitis 、 Medicine 、 Hepatitis 、 Pericholangitis 、 Pathology 、 Cirrhosis 、 Liver disease 、 Ulcerative colitis 、 Inflammatory bowel disease 、 Internal medicine 、 Primary biliary cirrhosis
摘要: Hepatobiliary abnormalities occur frequently in patients with inflammatory bowel disease (IBD). The association between ulcerative colitis and liver was described as early 1874. 126 Initial studies suggested that hepatobiliary complications occurred more than Crohn's disease, but subsequent have confirmed similar frequency disease. 32,46,98,99 A large number of now been IBD, follows: Primary sclerosing cholangitis PSC Pericholangitis Cirrhosis Chronic hepatitis Cholangiocarcinoma Fatty Amyloidosis Granulomatous Biliary lithiasis biliary cirrhosis Hepatic abscess Portal vein thrombosis most commonly reported disorders include PSC, pericholangitis, chronic hepatitis, cryptogenic cirrhosis, cholelithiasis. 46,134
sci-hub.se 参考文章(144)
M. Rabinovitz, R. R. Schade, W. B. Silverman, Madhukar Kaw, Biliary tract calculi in primary sclerosing cholangitis. The American Journal of Gastroenterology. ,vol. 90, pp. 72- 75 ,(1995)
Nicholas F. LaRusso, Keith D. Lindor, Roberta A. Jorgensen, Alan F. Hofmann, Monte L. Anderson, Gregory J. Gores, Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study. The American Journal of Gastroenterology. ,vol. 91, pp. 511- 515 ,(1996)
K. M. Abu-Elmagd, R. A. F. Krom, D. H. Van Thiel, P. A. Murtaugh, J. J. Fung, T. E. Starzl, M. Malinchoc, E. R. Dickson, A. J. Demetris, A. L. Langworthy, Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surgery gynecology & obstetrics. ,vol. 177, pp. 335- 344 ,(1993)
De Maria N, Van Thiel Dh, Rosenbloom E, Colantoni A, Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2-year period. Hepato-gastroenterology. ,vol. 43, pp. 1472- 1479 ,(1996)
Ludwig J, Surgical pathology of the syndrome of primary sclerosing cholangitis. The American Journal of Surgical Pathology. pp. 43- ,(1989)
Jeffers L, de Medina M, Alberti-Flor Jj, Schultz Dr, Schiff Er, Elevated levels of immunoglobulins and immune complexes in the bile of patients with primary sclerosing cholangitis. The American Journal of Gastroenterology. ,vol. 81, pp. 325- 328 ,(1986) , 10.1111/J.1572-0241.1986.TB01491.X
T. A. Knox, M. M. Kaplan, Treatment of primary sclerosing cholangitis with oral methotrexate. The American Journal of Gastroenterology. ,vol. 86, pp. 546- 552 ,(1991)
Giorgio Senaldi, Peter T. Donaldson, Silvio Magrin, J.Mark Farrant, Graeme J.M. Alexander, Diego Vergani, Roger Williams, Activation of the complement system in primary sclerosing cholangitis Gastroenterology. ,vol. 97, pp. 1430- 1434 ,(1989) , 10.1016/0016-5085(89)90386-7
Valérie Vilgrain, Serge Erlinger, Jacques Belghiti, Claude Degott, Yves Menu, Henri Nahum, Cholangiographic appearance simulating sclerosing cholangitis in metastatic adenocarcinoma of the liver Gastroenterology. ,vol. 99, pp. 850- 853 ,(1990) , 10.1016/0016-5085(90)90979-B
Nora V. Bergasa, Thomas L. Talbot, David W. Alling, Joseph M. Schmitt, Elijah C. Walker, Bennie L. Baker, Julia C. Korenman, Yoon Park, Jay H. Hoofnagle, E.Anthony Jones, A controlled trial of naloxone infusions for the pruritus of chronic cholestasis Gastroenterology. ,vol. 102, pp. 544- 549 ,(1992) , 10.1016/0016-5085(92)90102-5